Feasibility study of chemoradiotherapy followed by amrubicin and cisplatin for limited‐disease small cell lung cancer

To evaluate the feasibility of amrubicin plus cisplatin (AP) following chemoradiotherapy for limited‐disease small‐cell lung cancer, chemo‐naïve patients aged 20–70 years with a performance status of 0 or 1 and normal organ functions were treated with etoposide 100 mg/m(2) on days 1–3, cisplatin 80...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Sci
Hlavní autoři: Sekine, Ikuo, Sumi, Minako, Satouchi, Miyako, Tsujino, Kayoko, Nishio, Makoto, Kozuka, Takuyo, Niho, Seiji, Nihei, Keiji, Yamamoto, Nobuyuki, Harada, Hideyuki, Ishikura, Satoshi, Tamura, Tomohide
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2016
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4814250/
https://ncbi.nlm.nih.gov/pubmed/26748638
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12875
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky